882 results on '"Fassò, A."'
Search Results
52. D-STEM v2: A Software for Modeling Functional Spatio-Temporal Data
53. Modeling Spatiotemporal Mismatch for Aerosol Profiles
54. Safety, clinical activity and biomarker assessments of atezolizumab from a Phase I study in advanced/recurrent ovarian and uterine cancers
55. Platinum ineligibility and survival outcomes in patients with advanced urothelial carcinoma receiving first-line treatment.
56. On the Kalman Smoother Interpolation Error Distribution in Collocation Comparison of Atmospheric Profiles
57. Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab
58. Secondary Cosmic Ray particles due to GCR interactions in the Earth's atmosphere
59. Spatial Coverage of Monitoring Networks : A Climate Observing System Simulation Experiment
60. Geometry of Invariant Tori of Certain Integrable Systems with Symmetry and an Application to a Nonholonomic System
61. The hadronic models for cosmic ray physics: the FLUKA code solutions
62. A QMD description of the interaction of ion beams with matter
63. Heavy-ion collisions described by a new QMD code interfaced to FLUKA: model validation by comparisons with experimental data concerning neutron and charged fragment production
64. Safety and clinical activity of atezolizumab in head and neck cancer: results from a phase I trial
65. Safety and clinical activity of atezolizumab monotherapy in metastatic non-small-cell lung cancer: final results from a phase I study
66. The FLUKA Monte Carlo, non-perturbative QCD and Cosmic Ray cascades
67. The physics models of FLUKA: status and recent development
68. The FLUKA code: present applications and future developments
69. The Virtual Monte Carlo
70. Integrability and Dynamics of the n-Dimensional Symmetric Veselova Top
71. Geometry of KAM tori for nearly integrable Hamiltonian systems
72. Distributions of secondary muons at sea level from cosmic gamma rays below 10 TeV
73. Predicting Neutron Production from Cosmic-ray Muons
74. Spatial and Energy Distribution of Muons in Gamma-induced Air Showers
75. Stability Properties of the Riemann Ellipsoids
76. Navigating, Negotiating and Nullifying Contradictions in the Research Around School Curriculum Change
77. Wire scanners in low energy accelerators
78. L’incerta qualificazione giuridica e fiscale delle valute virtuali nella prospettiva del diritto penale e penale tributario
79. Il ruolo della Corte di giustizia nell’interpretazione del diritto europeo: riflessioni a margine di una recente pronuncia in tema di assicurazione diretta diversa dall’assicurazione sulla vita
80. L’imposizione indiretta del “trust dopo di noi”
81. Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma
82. Application of Functional Principal Component Analysis in the Spatiotemporal Land-Use Regression Modeling of PM2.5
83. Supplementary Figures from Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab
84. Supplementary Data from Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study
85. Supplementary Data Tables from Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab
86. Supplementary Figure 1 from Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
87. Data from Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
88. Correction: Adaptive LASSO estimation for functional hidden dynamic geostatistical models (Stochastic Environmental Research and Risk Assessment, (2023), 10.1007/s00477-023-02466-5)
89. European Population Exposure to Airborne Pollutants Based on a Multivariate Spatio-Temporal Model
90. Supplementary Data from Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study
91. Data from Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab
92. Supplementary Figures from Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab
93. Supplementary Data Tables from Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of Atezolizumab
94. Data from Safety and Clinical Activity of Atezolizumab in Patients with Metastatic Castration-Resistant Prostate Cancer: A Phase I Study
95. Supplementary Figure 1 from Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
96. Tumor immune microenvironment and genomic evolution in a patient with metastatic triple negative breast cancer and a complete response to atezolizumab
97. CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy
98. Overview of the FLUKA code
99. Seismomatics
100. Principles of Monte Carlo Calculations and Codes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.